FAPESP is a member of the Global Alliance for Chronic Diseases (GACD), a consortium of public health research funding agencies that supports research on chronic non-communicable diseases.
Headquartered in London, the GACD funds programs of research on lifestyle-related or chronic diseases, such as cardiovascular diseases, diabetes, certain cancers, lung diseases and mental disorders.
The alliance coordinates and supports research activities that address the prevention and treatment of chronic non-communicable diseases on a global scale. These conditions account for 60% of deaths worldwide, according to the GACD, which focuses on the needs of low- and middle-income countries, as well as vulnerable populations of more developed countries.
The GACD is the first collaboration of major research funding agencies to address chronic non-communicable diseases specifically. Together, the members of the alliance represent over 80% of public health research funding worldwide.
The GACD’s members include Australia’s National Health & Medical Research Council, the Canadian Institutes of Health Research, the Chinese Academy of Medical Sciences, the UK’s Medical Research Council, the Japan Agency for Medical Research & Development, the European Commission’s Health Directorate at the Research & Innovation DG, and the US National Institutes of Health.
Call for proposals 2017 (text in Portuguese; eligibility queries until March 10)